Tetronothiodin, a novel cholecystokinin type-B receptor antagonist produced by Streptomyces sp. NR0489. III. Structural elucidation.

Tetronothiodin (1) is a potent and selective cholecystokinin type B (CCK-B) receptor antagonist produced by Streptomyces sp. NR0489. Its structure was elucidated to be a macrocyclic compound comprising cyclohexene, alpha-acyltetronic acid and tetrahydrothiophene moieties based on various 2D NMR experiments on 1 and its dihydro derivative. The stereochemistries for the cyclohexene and tetrahydrothiophene rings were elucidated based on the analysis of NOEs obtained by NOESY experiments and NOE difference spectroscopy. The relative configuration of the cyclohexene moiety in 1 was revealed to be the same as that of the corresponding part in kijanimicin and chlorothricin, which can be structurally related to 1 in terms of their containing a cyclohexene ring with a spirotetronic acid in the molecule.

[1]  Y. Anzai,et al.  Tetronothiodin, a novel cholecystokinin type-B receptor antagonist produced by Streptomyces sp. NR0489. I. Taxonomy, yield improvement and fermentation. , 1993, The Journal of antibiotics.

[2]  H. Kotaki,et al.  Tetronothiodin, a novel cholecystokinin type-B receptor antagonist produced by Streptomyces sp. NR0489. II. Isolation, characterization and biological activities. , 1993, The Journal of antibiotics.

[3]  R. Chang,et al.  Novel and potent gastrin and brain cholecystokinin antagonists from Streptomyces olivaceus. Taxonomy, fermentation, isolation, chemical conversions, and physico-chemical and biochemical properties. , 1991, The Journal of antibiotics.

[4]  M. Kenig,et al.  MM 46115, a new antiviral antibiotic from Actinomadura pelletieri. Characteristics of the producing cultures, fermentation, isolation, physico-chemical and biological properties. , 1990, The Journal of antibiotics.

[5]  M. Toda,et al.  Cholecystokinin antagonism by anthramycin, a benzodiazepine antibiotic, in the central nervous system in mice , 1989, Brain Research.

[6]  K. Achiwa,et al.  Thiocarbonyl ylides. VI. New generation of thiocarbonyl ylides from organosilicon compounds containing sulfur and their 1,3-cycloadditions. , 1987 .

[7]  J. J. Lee,et al.  Further studies on the biosynthesis of chlorothricin. , 1986, The Journal of antibiotics.

[8]  R. Chang,et al.  Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Fermentation, isolation and biological properties. , 1985, The Journal of antibiotics.

[9]  D. Davies,et al.  Structure of antibiotic M139603; X-ray crystal structure of the 4-bromo-3,5-dinitrobenzoyl derivative , 1982 .

[10]  A. McPhail,et al.  Kijanimicin. Part 3. Structure and absolute stereochemistry of kijanimicin , 1981 .

[11]  A. McPhail,et al.  Kijanimicin. 2. Structure and absolute stereochemistry of kijanimicin , 1981 .

[12]  T. Tamaoki,et al.  Tetrocarcins, novel antitumor antibiotics. II. Isolation, characterization and antitumor activity. , 1980, The Journal of antibiotics.

[13]  J. Jacobsen,et al.  USE OF SINGLY AND DOUBLY LABELED (13C)ACETATE IN THE ELUCIDATION OF THE STRUCTURE OF CAROLIC ACID , 1977 .

[14]  W. Keller-Schierlein,et al.  Stoffwechselprodukte von Mikroorganismen. 107. Mitteilung [1]. Die Struktur des Chlorothricins, eines neuartigen Makrolid-Antibioticums , 1972 .